Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 16 entries
Sorted by: Best Match Show Resources per page
Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis.

Frontiers in molecular neuroscience

Quandt JA, Becquart P, Kamma E, Hallenbeck J.
PMID: 31507371
Front Mol Neurosci. 2019 Aug 27;12:190. doi: 10.3389/fnmol.2019.00190. eCollection 2019.

E-selectin plays an important role in mediating the rolling of leukocytes along and thus, the subsequent extravasation across activated endothelial cells comprising the microvasculature of the blood brain barrier (BBB). In multiple sclerosis (MS) and other inflammatory disorders of...

Cite
Quandt JA, Becquart P, Kamma E, et al. Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis. Front Mol Neurosci. 2019;12:190doi: 10.3389/fnmol.2019.00190.
Quandt, J. A., Becquart, P., Kamma, E., & Hallenbeck, J. (2019). Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis. Frontiers in molecular neuroscience, 12190. https://doi.org/10.3389/fnmol.2019.00190
Quandt, Jacqueline A, et al. "Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis." Frontiers in molecular neuroscience vol. 12 (2019): 190. doi: https://doi.org/10.3389/fnmol.2019.00190
Quandt JA, Becquart P, Kamma E, Hallenbeck J. Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis. Front Mol Neurosci. 2019 Aug 27;12:190. doi: 10.3389/fnmol.2019.00190. eCollection 2019. PMID: 31507371; PMCID: PMC6718462.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes.

Multiple sclerosis and related disorders

Kamma E, Becquart P, Traboulsee A, Schabas A, Vavasour IM, Laule C, Vilariño-Güell C, Quandt JA.
PMID: 34638097
Mult Scler Relat Disord. 2021 Nov;56:103269. doi: 10.1016/j.msard.2021.103269. Epub 2021 Sep 20.

CD5 antigen-like (CD5L) protein is a macrophage-secreted protein with roles in immunomodulation and lipid homeostasis. We compared serum CD5L levels in healthy controls to individuals diagnosed with clinically isolated syndrome, relapsing remitting (RR), secondary progressive (SP), and primary progressive...

Cite
Kamma E, Becquart P, Traboulsee A, et al. Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes. Mult Scler Relat Disord. 2021;56:103269doi: 10.1016/j.msard.2021.103269.
Kamma, E., Becquart, P., Traboulsee, A., Schabas, A., Vavasour, I. M., Laule, C., Vilariño-Güell, C., & Quandt, J. A. (2021). Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes. Multiple sclerosis and related disorders, 56103269. https://doi.org/10.1016/j.msard.2021.103269
Kamma, Emily, et al. "Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes." Multiple sclerosis and related disorders vol. 56 (2021): 103269. doi: https://doi.org/10.1016/j.msard.2021.103269
Kamma E, Becquart P, Traboulsee A, Schabas A, Vavasour IM, Laule C, Vilariño-Güell C, Quandt JA. Elevated levels of serum CD5 antigen-like protein distinguish secondary progressive multiple sclerosis from other disease subtypes. Mult Scler Relat Disord. 2021 Nov;56:103269. doi: 10.1016/j.msard.2021.103269. Epub 2021 Sep 20. PMID: 34638097.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C, Rakedzon T, Baram-Tsabari A.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., Laule, C., Rakedzon, T., & Baram-Tsabari, A. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C, Rakedzon T, Baram-Tsabari A. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households.

One health (Amsterdam, Netherlands)

Fritz M, Rosolen B, Krafft E, Becquart P, Elguero E, Vratskikh O, Denolly S, Boson B, Vanhomwegen J, Gouilh MA, Kodjo A, Chirouze C, Rosolen SG, Legros V, Leroy EM.
PMID: 33169106
One Health. 2021 Jun;11:100192. doi: 10.1016/j.onehlt.2020.100192. Epub 2020 Nov 04.

In a survey of household cats and dogs of laboratory-confirmed COVID-19 patients, we found a high seroprevalence of SARS-CoV-2 antibodies, ranging from 21% to 53%, depending on the positivity criteria chosen. Seropositivity was significantly greater among pets from COVID-19+...

Cite
Fritz M, Rosolen B, Krafft E, et al. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health. 2020;11:100192doi: 10.1016/j.onehlt.2020.100192.
Fritz, M., Rosolen, B., Krafft, E., Becquart, P., Elguero, E., Vratskikh, O., Denolly, S., Boson, B., Vanhomwegen, J., Gouilh, M. A., Kodjo, A., Chirouze, C., Rosolen, S. G., Legros, V., & Leroy, E. M. (2021). High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One health (Amsterdam, Netherlands), 11100192. https://doi.org/10.1016/j.onehlt.2020.100192
Fritz, Matthieu, et al. "High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households." One health (Amsterdam, Netherlands) vol. 11 (2021): 100192. doi: https://doi.org/10.1016/j.onehlt.2020.100192
Fritz M, Rosolen B, Krafft E, Becquart P, Elguero E, Vratskikh O, Denolly S, Boson B, Vanhomwegen J, Gouilh MA, Kodjo A, Chirouze C, Rosolen SG, Legros V, Leroy EM. High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households. One Health. 2021 Jun;11:100192. doi: 10.1016/j.onehlt.2020.100192. Epub 2020 Nov 04. PMID: 33169106; PMCID: PMC7641531.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels.

Multiple sclerosis and related disorders

Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C.
PMID: 34871858
Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26.

We characterized the frequency of diffusely abnormal white matter (DAWM) across a broad spectrum of multiple sclerosis (MS) participants. 35% of clinically isolated syndrome (CIS), 57% of relapsing remitting and 64% of secondary progressive MS participants demonstrated DAWM. CIS...

Cite
Vavasour IM, Becquart P, Gill J, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021;57:103422doi: 10.1016/j.msard.2021.103422.
Vavasour, I. M., Becquart, P., Gill, J., Zhao, G., Yik, J. T., Traboulsee, A., Carruthers, R. L., Kolind, S. H., Schabas, A. J., Sayao, A. L., Devonshire, V., Tam, R., Moore, G. R. W., Stukas, S., Wellington, C. L., Quandt, J. A., Li, D. K. B., & Laule, C. (2021). Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Multiple sclerosis and related disorders, 57103422. https://doi.org/10.1016/j.msard.2021.103422
Vavasour, I M, et al. "Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels." Multiple sclerosis and related disorders vol. 57 (2021): 103422. doi: https://doi.org/10.1016/j.msard.2021.103422
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, Carruthers RL, Kolind SH, Schabas AJ, Sayao AL, Devonshire V, Tam R, Moore GRW, Stukas S, Wellington CL, Quandt JA, Li DKB, Laule C. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. Mult Scler Relat Disord. 2021 Nov 26;57:103422. doi: 10.1016/j.msard.2021.103422. Epub 2021 Nov 26. PMID: 34871858.
Copy Download .nbib Format: NLM
Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide.

The open virology journal

Carthagena L, Becquart P, Hocini H, Kazatchkine MD, Bouhlal H, Belec L.
PMID: 21660187
Open Virol J. 2011;5:27-34. doi: 10.2174/1874357901105010027. Epub 2011 Apr 15.

Lactoferrin (LF), a multifunctional molecule present in human secretions, has potent inhibitory activities against human immunodeficiency virus (HIV). The aim of the study was to evaluate whether human LF (hLF) and its exposed domain LF-33 represented by the peptide...

Cite
Carthagena L, Becquart P, Hocini H, et al. Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide. Open Virol J. 2011;5:27-34doi: 10.2174/1874357901105010027.
Carthagena, L., Becquart, P., Hocini, H., Kazatchkine, M. D., Bouhlal, H., & Belec, L. (2011). Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide. The open virology journal, 527-34. https://doi.org/10.2174/1874357901105010027
Carthagena, Laetitia, et al. "Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide." The open virology journal vol. 5 (2011): 27-34. doi: https://doi.org/10.2174/1874357901105010027
Carthagena L, Becquart P, Hocini H, Kazatchkine MD, Bouhlal H, Belec L. Modulation of HIV Binding to Epithelial Cells and HIV Transfer from Immature Dendritic Cells to CD4 T Lymphocytes by Human Lactoferrin and its Major Exposed LF-33 Peptide. Open Virol J. 2011;5:27-34. doi: 10.2174/1874357901105010027. Epub 2011 Apr 15. PMID: 21660187; PMCID: PMC3109640.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 16 entries